Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Liver Diseases

  Free Subscription


04.03.2024

1 Am J Pathol
1 Biochem Biophys Res Commun
3 BMC Cancer
5 BMC Gastroenterol
1 Cancer Res
1 Dig Dis Sci
5 Gastroenterology
5 Gut
2 J Gastroenterol
2 J Gastroenterol Hepatol
1 J Hepatol
3 N Engl J Med
2 Oncogene
2 PLoS One
1 Radiol Imaging Cancer
2 Radiology
1 Transplant Proc
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Pathol

  1. NEWBERRY EP, Molitor EA, Liu A, Chong K, et al
    Impaired hepatic VLDL secretion promotes tumorigenesis and is accelerated with Fabp1 deletion.
    Am J Pathol. 2024 Feb 26:S0002-9440(24)00074.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  2. WU M, Tie M, Hu L, Yang Y, et al
    Fatty liver disease protective MTARC1 p.A165T variant reduces the protein stability of MTARC1.
    Biochem Biophys Res Commun. 2024;702:149655.
    PubMed         Abstract available


    BMC Cancer

  3. DA X, Cao B, Mo J, Xiang Y, et al
    Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets.
    BMC Cancer. 2024;24:273.
    PubMed         Abstract available

  4. OUYANG Y, Gu Y, Zhang X, Huang Y, et al
    AMPKalpha2 promotes tumor immune escape by inducing CD8+ T-cell exhaustion and CD4+ Treg cell formation in liver hepatocellular carcinoma.
    BMC Cancer. 2024;24:276.
    PubMed         Abstract available

  5. JIN Y, Ren H, Yue Q, Wu W, et al
    Surrogacy of one-year survival for overall survival in advanced hepatocellular carcinoma.
    BMC Cancer. 2024;24:258.
    PubMed         Abstract available


    BMC Gastroenterol

  6. LIU JP, Song SH, Shi PM, Qin XY, et al
    miR-541 is associated with the prognosis of liver cirrhosis and directly targets JAG2 to inhibit the activation of hepatic stellate cells.
    BMC Gastroenterol. 2024;24:84.
    PubMed         Abstract available

  7. WANG M, Tang S, Li G, Huang Z, et al
    Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients.
    BMC Gastroenterol. 2024;24:81.
    PubMed         Abstract available

  8. ZHOU J, Ye D, Zhang S, Ding J, et al
    The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation.
    BMC Gastroenterol. 2024;24:85.
    PubMed         Abstract available

  9. WANG Z, Liu Z, Zheng J, Huang L, et al
    The effects of low-dose IL-2 on Th17/Treg cell imbalance in primary biliary cholangitis mouse models.
    BMC Gastroenterol. 2024;24:87.
    PubMed         Abstract available

  10. RITACCIO G, Barritt Iv AS, Conklin JL, Richardson DR, et al
    Scoping review of values elicitation tools for treatment decisions in hepatocellular carcinoma.
    BMC Gastroenterol. 2024;24:90.
    PubMed         Abstract available


    Cancer Res

  11. WANG Y, Cheng C, Lu Y, Lian Z, et al
    beta-catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma.
    Cancer Res. 2024 Feb 28. doi: 10.1158/0008-5472.CAN-23-0673.
    PubMed         Abstract available


    Dig Dis Sci

  12. KALAITZAKIS ZE, Giahnakis E, Koutroubakis IE, Mouzas IA, et al
    Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study.
    Dig Dis Sci. 2024 Feb 27. doi: 10.1007/s10620-023-08223.
    PubMed         Abstract available


    Gastroenterology

  13. HOLTZ LR, DeBosch BJ
    Deploying Lactulose as a Prebiotic to Reduce Complications of Chronic Liver Disease.
    Gastroenterology. 2024;166:534-535.
    PubMed        

  14. URIAS E, Tedesco NR, Oliveri A, Raut C, et al
    PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment.
    Gastroenterology. 2024;166:515-517.
    PubMed        

  15. GAO F, Seto WK, Zheng MH
    Preventing Overdiagnosis of Nonalcoholic Fatty Liver Disease: Established Cutoff Values for Transient Elastography Are Needed.
    Gastroenterology. 2024;166:541-542.
    PubMed        

  16. AN T, Liu L, Li X
    Factors Associated With the Influence of Liver Fibrosis Should Be Fully Considered.
    Gastroenterology. 2024;166:540-541.
    PubMed        

  17. CHEN J, Feng W, Sun M, Huang W, et al
    TGF-beta1 Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis through Transcriptionally Upregulating PD-L1 and CXCL12.
    Gastroenterology. 2024 Feb 26:S0016-5085(24)00187.
    PubMed         Abstract available


    Gut

  18. QIAN Z, Liang J, Huang R, Song W, et al
    HBV integrations reshaping genomic structures promote hepatocellular carcinoma.
    Gut. 2024 Feb 23:gutjnl-2023-330414. doi: 10.1136/gutjnl-2023-330414.
    PubMed         Abstract available

  19. HUNTER H, Johnston AJ, Said W, Wong NA, et al
    Colonic spider naevi in a middle-aged man.
    Gut. 2024;73:441-520.
    PubMed        

  20. GREEN BL, Myojin Y, Ma C, Ruf B, et al
    Immunosuppressive CD29(+) Treg accumulation in the liver in mice on checkpoint inhibitor therapy.
    Gut. 2024;73:509-520.
    PubMed         Abstract available

  21. CUBERO FJ, Sarobe P, Tiegs G
    Advancing with cancer immunotherapeutics: CD29(+) regulatory T cell antagonism.
    Gut. 2024;73:391-392.
    PubMed        

  22. LEE HH, Lee HA, Kim EJ, Kim HY, et al
    Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease.
    Gut. 2024;73:533-540.
    PubMed         Abstract available


    J Gastroenterol

  23. WANG J, Zhang H, Chen L, Fu K, et al
    CircDCBLD2 alleviates liver fibrosis by regulating ferroptosis via facilitating STUB1-mediated PARK7 ubiquitination degradation.
    J Gastroenterol. 2024;59:229-249.
    PubMed         Abstract available

  24. WU C, Li J, Jia H, Zhao J, et al
    Indoleamine 2,3-dioxygenase 1-mediated iron metabolism in macrophages contributes to lipid deposition in nonalcoholic steatohepatitis.
    J Gastroenterol. 2024 Feb 24. doi: 10.1007/s00535-024-02082.
    PubMed         Abstract available


    J Gastroenterol Hepatol


  25. Correction to "Hepatobiliary and Pancreatic: Challenges in the diagnosis of hepatic nodules in patients with alcoholic liver cirrhosis".
    J Gastroenterol Hepatol. 2024 Feb 25. doi: 10.1111/jgh.16529.
    PubMed        

  26. TADA T, Kumada T, Hiraoka A, Kariyama K, et al
    mADRES predicts hepatocellular carcinoma development in patients with hepatitis C virus who achieved sustained virological response.
    J Gastroenterol Hepatol. 2024 Feb 25. doi: 10.1111/jgh.16512.
    PubMed         Abstract available


    J Hepatol

  27. XIE P, Yu M, Zhang B, Yu Q, et al
    CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma.
    J Hepatol. 2024 Feb 23:S0168-8278(24)00129-6. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available


    N Engl J Med

  28. ASSIS DN
    Advancing Second-Line Treatment for Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:853-854.
    PubMed        

  29. HIRSCHFIELD GM, Bowlus CL, Mayo MJ, Kremer AE, et al
    A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:783-794.
    PubMed         Abstract available

  30. SCHNABL B
    PPAR Agonists in Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:855-858.
    PubMed        


    Oncogene

  31. ZHANG T, Zhao F, Zhang Y, Shi JH, et al
    Targeting the IRE1alpha-XBP1s axis confers selective vulnerability in hepatocellular carcinoma with activated Wnt signaling.
    Oncogene. 2024 Feb 28. doi: 10.1038/s41388-024-02988.
    PubMed         Abstract available

  32. FENG Z, Yin J, Zhang Z, Chen Z, et al
    O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation.
    Oncogene. 2024 Feb 23. doi: 10.1038/s41388-024-02977.
    PubMed         Abstract available


    PLoS One

  33. LADNER DP, Gmeiner M, Hasjim BJ, Mazumder N, et al
    Increasing prevalence of cirrhosis among insured adults in the United States, 2012-2018.
    PLoS One. 2024;19:e0298887.
    PubMed         Abstract available

  34. ELGUEZABAL RODELO RG, Porchia LM, Torres-Rasgado E, Lopez-Bayghen E, et al
    Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018.
    PLoS One. 2024;19:e0298662.
    PubMed         Abstract available


    Radiol Imaging Cancer

  35. DOU Q, Grant AK, Coutinto de Souza P, Moussa M, et al
    Characterizing Metabolic Heterogeneity of Hepatocellular Carcinoma with Hyperpolarized (13)C Pyruvate MRI and Mass Spectrometry.
    Radiol Imaging Cancer. 2024;6:e230056.
    PubMed         Abstract available


    Radiology

  36. CANNELLA R, Matteini F, Dioguardi Burgio M, Sartoris R, et al
    Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
    Radiology. 2024;310:e231160.
    PubMed         Abstract available

  37. KARTALIS N, Grigoriadis A
    LI-RADS in Patients with Solitary Resected Hepatocellular Carcinoma: Glancing beyond Diagnosis.
    Radiology. 2024;310:e240161.
    PubMed        


    Transplant Proc

  38. COSTA PEG, Garcia JHP, Coelho GR, Barros MAP, et al
    Hepatocellular Carcinoma in Ceara: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil.
    Transplant Proc. 2024 Feb 28:S0041-1345(24)00009.
    PubMed         Abstract available


    Transplantation

  39. BECKER EC, Siddique O, O'Sullivan DM, Dar W, et al
    Disparities in Liver Transplantation for Nonalcoholic Steatohepatitis in Women.
    Transplantation. 2024 Feb 29. doi: 10.1097/TP.0000000000004964.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.